PROMISS Diagnostics
PrivateLast Round
Seed
Jan 9, 2020
Total Funding Raised
$420,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PROMISS Diagnostics operates in Healthcare & Life Sciences and is based in Wauwatosa, Wisconsin. Its latest recorded funding round was a Seed round in January 2020.
PROMISS Diagnostics is a biotechnology company that develops a non-invasive, machine-learning-based clinical diagnostic test for the early detection of ovarian cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PROMISS Diagnostics Comparables
Compare PROMISS Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOA Dx | 91% | |
| CpG Diagnostics, Inc. | 87% | |
| MyOncoDx, Inc. | 86% |
For institutional investors. Book with your work email.
PROMISS Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 9, 2020 | ||||
| Grant | Nov 9, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PROMISS Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bridge to Cures | Grant |
| Wisconsin Alumni Research Foundation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 461% MoM.
- Jan 23, 2026
Monthly visitors increased 57% MoM.
For institutional investors. Book with your work email.
PROMISS Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PROMISS Diagnostics's valuation, stock price, and market status.
Is PROMISS Diagnostics a public or private company?
PROMISS Diagnostics is a private company.
What is the current stock price of PROMISS Diagnostics?
PROMISS Diagnostics is a private company, so its shares have no public market price. Caplight tracks PROMISS Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PROMISS Diagnostics worth (valuation)?
Valuation information for PROMISS Diagnostics is not publicly available.
Can I buy PROMISS Diagnostics stock?
PROMISS Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PROMISS Diagnostics's last funding round?
PROMISS Diagnostics's most recent funding round was Seed on January 9, 2020.
Who are the main investors in PROMISS Diagnostics?
Key investors in PROMISS Diagnostics include Wisconsin Alumni Research Foundation.
Will PROMISS Diagnostics IPO soon?
No public IPO plans have been announced for PROMISS Diagnostics.
How can I track PROMISS Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in PROMISS Diagnostics's shares on secondary markets.